Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501) (Q54634140)
Jump to navigation
Jump to search
scientific article published on January 1, 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501) |
scientific article published on January 1, 2010 |
Statements
Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501) (English)
Y. Niibe
J. Watanabe
S. Tsunoda
M. Arai
T. Arai
M. Kawaguchi
K. Matsuo
T. Jobo
S. Ono
A. Numata
N. Unno